Listed

Champions Oncology, Inc.: Form 10-K for the period ended Apr 30, 2013

Filed with the SEC on Jul 26, 2013 and accepted by EDGAR at Jul 26, 2013, 16:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2013-04-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Research and development12 months2012-05-01 to 2013-04-30$1.9mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2012-05-01 to 2013-04-30−$6.2mus-gaap:OperatingIncomeLoss
Income tax12 months2012-05-01 to 2013-04-30$10.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2012-05-01 to 2013-04-30−$6.3mus-gaap:NetIncomeLoss
Diluted EPS12 months2012-05-01 to 2013-04-30−$0.12us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2012-05-01 to 2013-04-30−$4.3mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2012-05-01 to 2013-04-30$57.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2013-04-30$9.6mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2013-04-30$10.4mus-gaap:AssetsCurrent
Total assetsAt period end2013-04-30$11.7mus-gaap:Assets
Current liabilitiesAt period end2013-04-30$2.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2013-04-30$4.0mus-gaap:Liabilities
Shareholders' equityAt period end2013-04-30−$9.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-13-041406. Last ingested by Listed: Nov 10, 2026, 03:33 ET. Listed shows no prices and gives no investment advice.